NURSING 660 MIDTERM QUESTIONS PHARM

NURSING 660 MIDTERM QUESTIONS PHARMA child is diagnosed with hypothyroidism. The nurse anticipates an order for the drug of choice when treating children, which is what? A) Liothyronine (Cytomel) B) Liotrix (Thyrolar) C) Levothyroxine (Synthroid) D) Methimazole (Tapazole) A patient is at risk for thrombosis formation and is taking an oral anticoagulant. The patient has been newly diagnosed with hypothyroidism and placed on levothyroxine (Synthroid). What will the nurse monitor the patient for? A) Tachycardia B) Elevated body temperature C) Increased time spent sleeping D) Increased bruising and bleeding The nurse is providing patient teaching regarding the administration of levothyroxine (Synthroid). What is the nurse's priority teaching point? A) "Take the medication after breakfast." B) "Take the medication with a full glass of water." C) "Remain in the upright position for 30 minutes after administering." D) "Take the medication before going to bed at night." The nurse instructs the patient with a new prescription to treat hyperthyroidism and includes the importance of regular lab studies to monitor for bone marrow suppression, which can be an adverse effect of this drug. What drug is the nurse teaching the patient about? A) Methimazole (Tapazole) B) Propylthiouracil (PTU) C) Sodium iodide I131 (Generic) D) Potassium iodide (Thyro-Block) What assessment findings would the nurse expect to see in a patient who overdosed on levothyroxine (Synthroid)? A) Nervousness, tachycardia, tremors B) Somnolence, bradycardia, paresthesia C) Hyperglycemia, hypertension, edema D) Buffalo hump, constipation, sodium loss After administering propylthiouracil (PTU), what effect would the nurse anticipate the drug will have in the patient's body? A) To destroy part of the thyroid gland B) To inhibit production of thyroid hormone in the thyroid gland C) To suppress the anterior pituitary gland's secretion of thyroid-stimulating hormone (TSH) D) To suppress the hypothalamus's production of thyrotropin-releasing hormone (TRH)